Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Bruxelles  >  Ablynx    ABLX   BE0003877942

ABLYNX (ABLX)
My previous session
Most popular
  Report  
SummaryQuotesNewsCalendarCompanyFinancialsRevisions 
 News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
Most relevant news about ABLYNX
07/10ACCELERON PHARMA : Appoints Robert K. Zeldin, M.D., Chief Medical Officer
AQ
07/06SANOFI : - CHMP recommends approval of Cablivi
AQ
06/22SANOFI : completes its acquisition of Ablynx following the expiration of the Squ..
AQ
06/19ABLYNX : Sanofi completes its acquitision of ablynx following the expiration of ..
GL
05/29ABLYNX : Crossing thresholds
CO
05/28ABLYNX : Publication in accordance with article 14 of the belgian law of 2 may 2..
GL
05/28ABLYNX : Publication in accordance with article 14 of the belgian law of 2 may 2..
GL
05/28ABLYNX : Crossing thresholds
CO
05/25ABLYNX : Notice in relation to the convertible bonds due may 2020
GL
05/25ABLYNX : Crossing thresholds
CO
05/21ABLYNX : Publication in accordance with article 14 of the belgian law of 2 may 2..
GL
05/17ABLYNX : 17/05/2018 ablynx announces warrant exercise
PU
05/17ABLYNX : Announces warrant exercise
GL
05/17ABLYNX : Announces warrant exercise
AQ
05/17ABLYNX : Threshold crossings
CO
More most relevant news
All news about ABLYNX
07/10ACCELERON PHARMA : Appoints Robert K. Zeldin, M.D., Chief Medical Officer
AQ
07/06SANOFI : - CHMP recommends approval of Cablivi
AQ
06/30Sanofi, Advent finally shake hands on $2.2B European generics sale
AQ
06/29ABLYNX : `Rapidly evolving` biotech company to create 10 jobs at York Science Pa..
AQ
06/29SANOFI : CHMP Recommends Approval of Cablivi (Caplacizumab)
AQ
06/22SANOFI : completes its acquisition of Ablynx following the expiration of the Squ..
AQ
06/21SANOFI : completes $3.9bn acquisition of Ablynx
AQ
06/20SANOFI : Completes Its Acquisition of Ablynx Following Expiration of Squeeze-Out..
AQ
06/19ABLYNX : Sanofi completes its acquitision of ablynx following the expiration of ..
GL
05/29ABLYNX : Crossing thresholds
CO
More news
Sector news : Biotechnology & Medical Research - NEC
08/16REGENERON PHARMACEUTICALS : Teva Report Positive Phase 3 Fasinumab Results
DJ
08/03Roche Drug for Brain Disease Granted European Fast-Track
DJ
08/02Regeneron Closes Up 7% After 2Q Earnings Beat -- Data Talk
DJ
08/02REGENERON PHARMACEUTICALS : Beats Earnings Estimates
DJ
07/31UNITED THERAPEUTICS : Medtronic Get FDA OK for Remodulin Implantable System
DJ
07/27JOHNSON & JOHNSON : J&J's Janssen Gets Positive CHMP Opinion for Darzalex as Fro..
DJ
More sector news : Biotechnology & Medical Research - NEC
Official Publications
05/29Crossing thresholds 
05/28Crossing thresholds 
05/25Crossing thresholds 
05/17Threshold crossings 
05/11Threshold crossings 
05/08Threshold crossings 
More official Publications
News from SeekingAlpha
05/02YOUR DAILY PHARMA SCOOP : KPTI Data, Allergan Write-Off, Celgene Down On Delay 
04/30Ablynx completes enrollment in mid-stage study of ALX-0171 in RSV 
03/26Ablynx's vobarilizumab flunks mid-stage lupus study 
03/02Mid-stage study underway in Japan for Ablynx ALX-0171 in RSV 
02/22Ablynx NV reports FY results 
01/30YOUR DAILY PHARMA SCOOP : Sanofi To Acquire Ablynx, PTC Therapeutics Announces D.. 
Financials (€)
Sales 2018 94,0 M
EBIT 2018 -9,76 M
Net income 2018 -
Debt 2018 -
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales 2018 37,2x
Capi. / Sales 2019 19,8x
Capitalization 3 498 M
Income Statement Evolution
Managers
NameTitle
Edwin Moses Chief Executive Officer & Executive Director
Russell G. Greig Chairman
Wim Ottevaere Chief Financial Officer
Robert Freisen Chief Scientific Officer
Remi Vermeiren Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
ABLYNX117.28%0
CELLTRION, INC.--.--%29 483
IQVIA HOLDINGS INC22.86%24 367
LONZA GROUP17.93%23 220
INCYTE CORPORATION-27.36%14 625
SEATTLE GENETICS, INC.39.51%11 852